Swiss National Bank Purchases 164,600 Shares of Tilray Inc (NASDAQ:TLRY)

Swiss National Bank raised its holdings in Tilray Inc (NASDAQ:TLRY) by 10.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,776,638 shares of the company’s stock after buying an additional 164,600 shares during the quarter. Swiss National Bank owned 0.19% of Tilray worth $2,363,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in TLRY. Verdence Capital Advisors LLC acquired a new stake in shares of Tilray during the 4th quarter valued at about $29,000. Ameritas Advisory Services LLC acquired a new stake in Tilray during the fourth quarter valued at approximately $32,000. Newman Dignan & Sheerar Inc. grew its stake in shares of Tilray by 61.9% in the 4th quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company’s stock valued at $35,000 after purchasing an additional 10,000 shares during the period. Jones Financial Companies Lllp raised its holdings in shares of Tilray by 125.7% in the 4th quarter. Jones Financial Companies Lllp now owns 31,725 shares of the company’s stock worth $42,000 after buying an additional 17,670 shares in the last quarter. Finally, Synovus Financial Corp lifted its position in shares of Tilray by 176.7% during the 3rd quarter. Synovus Financial Corp now owns 36,092 shares of the company’s stock worth $64,000 after buying an additional 23,046 shares during the period. Institutional investors and hedge funds own 9.35% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group increased their price objective on Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a research note on Monday, January 13th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Tilray has a consensus rating of “Hold” and a consensus target price of $2.70.

Tilray Price Performance

Shares of TLRY stock opened at $0.71 on Friday. Tilray Inc has a 1 year low of $0.58 and a 1 year high of $2.97. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. The firm’s 50 day moving average is $0.87 and its 200-day moving average is $1.27. The firm has a market capitalization of $669.49 million, a price-to-earnings ratio of -2.38 and a beta of 2.13.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings data on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). The firm had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. Sell-side analysts forecast that Tilray Inc will post -0.2 EPS for the current fiscal year.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.